Mycophenolic Acid

Category	Dengue virus
CAS	24280-93-1
Description	Mycophenolic acid is a small lactone antibiotic produced by Pen. brevicom pactum and Pen. stoloniferum. Activity against gram-positive bacteria. In animal experiments, it has inhibitory effect on sarcoma-180, Lewis lung cancer, adenocarcinoma Ca-755, Walker tumor 256, Yoshida sarcoma, Freund ascites tumor, etc. Mycophenolic acid is a potent IMPDH inhibitor and the active metabolite of an immunosuppressive drug, used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells.

Quotation Now

Product Information

Synonyms	mycophenolic acid;24280-93-1;Mycophenolate;Melbex;Myfortic;Mycophenolsaeure;483-60-3;Lilly-68618;Acido micofenolico;Micofenolico acido;(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid;NSC-129185;Acide mycophenolique;Acidum mycophenolicum;6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid;CCRIS 5565;NSC 129185;Ly 68618;(E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid;UNII-HU9DX48N0T;EINECS 246-119-3;HU9DX48N0T;(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid;DTXSID4041070;Acido micofenolico [INN-Spanish];CHEBI:168396;Acide mycophenolique [INN-French];Acidum mycophenolicum [INN-Latin];(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid;Mycophenolic Acid (MPA);MFCD00036814;NSC129185;Lilly 68618;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-;CHEMBL866;4-Hexenoic acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-, (E)-;4-Methyl-5-methoxy-7-hydroxy-6-(5-carboxy-3-methylpent-2-en-1-yl)-phthalide (E)-;6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methylhex-4-enoic acid;6-(1,3-Dihydro-7-hydroxy-5-methoxy-4-methyl-1-oxoisobenzofuran-6-yl)-4-methyl-4-hexanoic acid;6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid (E)-;Myfortic (mycophenolate sodium);4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4E)-;DTXCID2021070;EC 246-119-3;TNP00198;RS-61443 [AS MOFETIL];NCGC00016786-01;CAS-24280-93-1;Mycophenolic acid 100 microg/mL in Acetonitrile;6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid;4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4E)-;Acido micofenolico (INN-Spanish);MYCOPHENOLIC ACID (MART.);MYCOPHENOLIC ACID [MART.];Acide mycophenolique (INN-French);Acidum mycophenolicum (INN-Latin);Mycophenoic acid;6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid;Micofenolico acido [Spanish];(4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic Acid (Mycophenolic Acid);(E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid;6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid;MOA;SMR000471887;6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid;SR-01000597602;MYCOPHENOLATE MOFETIL IMPURITY F (EP IMPURITY);MYCOPHENOLATE MOFETIL IMPURITY F [EP IMPURITY];Mycophenolsaure;mycophenilic acid;mycophenolic-acid;(4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic Acid; Mycophenolate Mofetil Imp. F (EP); Mycophenolic Acid; Mycophenolate Mofetil Impurity F;Prestwick_817;EINECS 207-595-8;Mycophenolic acid [USAN:INN:BAN];MPA - Mycophenolate;Tocris-1505;1jr1;starbld0040186;Mycophenolic acid (TN);Prestwick2_000556;Prestwick3_000556;Spectrum5_001654;UPCMLD-DP028;4-Hexenoic acid, (E)-;Mycophenolate;RS-61443;SCHEMBL4549;Mycophenolic (Mycophenolate);Mycophenolic acid, >=98%;BSPBio_000631;BSPBio_002534;MYCOPHENOLATE [VANDF];MLS001074701;MLS002222265;MLS002695945;BIDD:GT0456;SPECTRUM1500674;MYCOPHENOLIC ACID [MI];BPBio1_000695;GTPL6832;MEGxm0_000120;Mycophenolic acid (USAN/INN);SCHEMBL2514376;Mycophenolate; Myfortic; Melbex;MYCOPHENOLIC ACID [INN];MYCOPHENOLIC ACID [USAN];UPCMLD-DP028:001;ACon0_000960;ACon1_000496;BDBM19264;CHEBI:92545;HMS500H08;EX-A975;L04AA06;MYCOPHENOLIC ACID [VANDF];HMS1569P13;HMS1921A18;HMS2089A17;HMS2092G22;HMS2096P13;HMS2268H22;HMS3403P09;HMS3412F09;HMS3676F09;Pharmakon1600-01500674;MYCOPHENOLIC ACID [WHO-DD];AMY40494;BCP05321;HY-B0421;Tox21_110610;BBL034696;CCG-39914;HB3987;NSC757424;s2487;STL419986;Mycophenolic acid, analytical standard;AKOS015888214;Tox21_110610_1;AC-4491;BCP9000970;DB01024;DS-1638;MYCOPHENOLIC ACID [ORANGE BOOK];NSC-757424;SDCCGMLS-0066618.P001;(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoic acid;IDI1_000146;NCGC00016786-02;NCGC00016786-03;NCGC00016786-04;NCGC00016786-05;NCGC00016786-06;NCGC00016786-07;NCGC00016786-08;NCGC00016786-09;NCGC00016786-10;NCGC00016786-11;NCGC00016786-12;NCGC00016786-15;NCGC00025190-01;NCGC00025190-02;NCGC00025190-03;NCGC00025190-04;NCGC00025190-05;NCGC00025190-07;NCGC00025190-08;NCGC00025190-09;NCGC00025190-10;(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxohydroisobenzofuran-5-yl)-4-methylhex -4-enoic acid;-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-;BM164624;Mycophenolic Acid - CAS 24280-93-1;SBI-0051945.P003;A-249;M2216;NS00000399;SW196951-2;C20380;D05096;EN300-122327;M 5255;M02087;AB00052466-13;AB00052466-14;AB00052466_15;AB00052466_16;EN300-1273238;A817192;Mycophenolate mofetil impurity, mycophenolic acid-;Q420553;SR-01000597602-1;SR-01000597602-3;SR-01000597602-4;BRD-K63750851-001-06-6;BRD-K63750851-001-13-2;BRD-K63750851-001-18-1;BRD-K63750851-001-19-9;BRD-K63750851-001-20-7;Z2315575694;MYCOPHENOLATE MOFETIL IMPURITY, MYCOPHENOLIC ACID- [USP IMPURITY];MYCOPHENOLATE MOFETIL IMPURITY, MYCOPHENOLIC ACID-(USP IMPURITY);Mycophenolic acid, powder, BioReagent, suitable for cell culture, >=98%;6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid;NSC 129185;6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthanlanyl)-4-methyl-4-hexanoic acid;(E)-6-(1,3-dihydro-4-hydroxy-6- methoxy-7-methyl-3-oxoisobenzofuran-5-yl)-4-methyl-4-hexenoic acid;(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxoisobenzofuran-5-yl)-4-methyl-4-hexenoic acid;1162256-90-7;4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4E)- (9CI);4-Hexenoic acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-, (E)- (8CI);4-Hexenoic acid,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5- isobenzofuranyl)-4-methyl-, (E)-;E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid;
IUPAC Name	(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid
Molecular Weight	373.7
Molecular Formula	C13H14BrClN4S
Canonical SMILES	C1=CC=NC(=C1)CCNC(=S)NC2=NC=C(C=C2)Br.Cl
InChI	InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+
InChIKey	HPNSFSBZBAHARI-RUDMXATFSA-N
Boiling Point	611.6°C at 760 mmHg
Melting Point	141°C
Purity	>98%
Density	1.29 g/cm3
Solubility	Soluble in ethanol, methanol, DMF or DMSO. Limited water solubility.
Appearance	Solid
Application	Antibiotics, Antineoplastic
Storage	-20°C